Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia

Cancer Cell

Volumn 10, Issue 4, 2006, Pages 257-268

  Somervaille, Tim C P ^a   Cleary, Michael L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CELLCYCLE; STEMCELL

Indexed keywords

HOX PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CANCER STAGING; CELL IMMORTALIZATION; CELL LINEAGE; CELL RENEWAL; CELL STRUCTURE; COLONY FORMING CELL; COMPARATIVE STUDY; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

MURINAE;

EID: 33749440584     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2006.08.020     Document Type: Article

References (47)

1. Ailles L.E., Gerhard B., Kawagoe H., and Hogge D.E. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood 94 (1999) 1761-1772
2. Ayton P.M., and Cleary M.L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20 (2001) 5695-5707
3. Bhowmick N.A., Neilson E.G., and Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 432 (2004) 332-337
4. Blair A., and Sutherland H.J. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp. Hematol. 28 (2000) 660-671
5. Blair A., Hogge D.E., Ailles L.E., Lansdorp P.M., and Sutherland H.J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89 (1997) 3104-3112
6. Boggs D.R. The total marrow mass of the mouse: A simplified method of measurement. Am. J. Hematol. 16 (1984) 277-286
7. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
8. Bonnet D., Bhatia M., Wang J.C., Kapp U., and Dick J.E. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant. 23 (1999) 203-209
9. Buick R.N., Till J.E., and McCulloch E.A. Colony assay for proliferative blast cells circulating in myeloblastic leukaemia. Lancet 1 (1977) 862-863
10. Cancelas J.A., Lee A.W., Prabhakar R., Stringer K.F., Zheng Y., and Williams D.A. Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. Nat. Med. 11 (2005) 886-891
11. Camargo F.D., Chambers S.M., Drew E., McNagny K.M., and Goodell M.A. Hematopoietic stem cells do not engraft with absolute efficiencies. Blood 107 (2006) 501-507
12. Castor A., Nilsson L., Astrand-Grundstrom I., Buitenhuis M., Ramirez C., Anderson K., Strombeck B., Garwicz S., Bekassy A.N., Schmiegelow K., et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat. Med. 11 (2005) 630-637
13. Collins L.S., and Dorshkind K. A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J. Immunol. 138 (1987) 1082-1087
14. Cozzio A., Passegue E., Ayton P.M., Karsunky H., Cleary M.L., and Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17 (2003) 3029-3035
15. DiMartino J.F., Ayton P.M., Chen E.H., Naftzger C.C., Young B.D., and Cleary M.L. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood 99 (2002) 3780-3785
16. Feuring-Buske M., Gerhard B., Cashman J., Humphries R.K., Eaves C.J., and Hogge D.E. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors. Leukemia 17 (2003) 760-763
17. Giles F.J., Keating A., Goldstone A.H., Avivi I., Willman C.L., and Kantarjian H.M. Acute myeloid leukemia. Hematology Am. Soc. Hematol. Educ. Program (2002) 73-110
18. Gu Y., Filippi M., Cancelas J.A., Siefring J.E., Williams E.P., Jasti A.C., Harris C.E., Lee A.W., Prabhakar R., Atkinson S.J., et al. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 302 (2003) 445-449
19. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
20. Hewitt H.B., Blake E., and Proter E.H. The effect of lethally irradiated cells on the transplantability of murine tumours. Br. J. Cancer 28 (1973) 123-135
21. Hewitt H.B., Blake E.R., and Walder A.S. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. Br. J. Cancer 33 (1976) 241-259
22. Hill R.P., and Milas L. The proportion of stem cells in murine tumors. Int. J. Radiat. Oncol. Biol. Phys. 16 (1989) 513-518
23. Hope K.J., Jin L., and Dick J.E. Human acute myeloid leukemia stem cells. Arch. Med. Res. 34 (2003) 507-514
24. Huntly B.J., Shigematsu H., Deguchi K., Lee B.H., Mizuno S., Duclos N., Rowan R., Amaral S., Curley D., Williams I.R., et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6 (2004) 587-596
25. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431 (2004) 997-1002
26. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., Gotlib J., Li K., Manz M.G., Keating A., et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351 (2004) 657-667
27. Johnson J.J., Chen W., Hudson W., Yao Q., Taylor M., Rabbitts T.H., and Kersey J.H. Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia. Blood 101 (2003) 3229-3235
28. Kodama H., Nose M., Niida S., and Nishikawa S. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp. Hematol. 22 (1994) 979-984
29. Krivtsov A.V., Twomey D., Feng Z., Stubbs M.C., Wang Y., Faber J., Levine J.E., Wang J., Hahn W.C., Gilliland D.G., et al. Transformation from committed progenitor to leukemia stem cell initiated by MLL-AF9. Nature 442 (2006) 818-822
30. Kummermehr J.C. Tumour stem cells-The evidence and the ambiguity. Acta Oncol. 40 (2001) 981-988
31. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
32. Lavau C., Szilvassy S.J., Slany R., and Cleary M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16 (1997) 4226-4237
33. Mackillop W.J., Ciampi A., Till J.E., and Buick R.N. A stem cell model of human tumor growth: Implications for tumor cell clonogenic assays. J. Natl. Cancer Inst. 70 (1983) 9-16
34. Miller C.L., and Eaves C.J. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc. Natl. Acad. Sci. USA 94 (1997) 13648-13653
35. Miyamoto T., Weissman I.L., and Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl. Acad. Sci. USA 97 (2000) 7521-7526
36. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., and Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121 (2005) 335-348
37. Pearce D.J., Taussig D., Zibara K., Smith L.L., Ridler C.M., Preudhomme C., Young B.D., Rohatiner A.Z., Lister T.A., and Bonnet D. AML engraftment in the NOD/SCID assay reflects the outcome of AML: Implications for our understanding of the heterogeneity of AML. Blood 107 (2006) 1166-1173
38. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., Nagler A., Ben-Hur H., Many A., Shultz L., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283 (1999) 845-848
39. Shultz L.D., Lyons B.L., Burzenski L.M., Gott B., Chen X., Chaleff S., Kotb M., Gillies S.D., King M., Mangada J., et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174 (2005) 6477-6489
40. Swansbury G.J., Slater R., Bain B.J., Moorman A.V., and Secker-Walker L.M. Hematological malignancies with t(9;11)(p21-22;q23)-A laboratory and clinical study of 125 cases. European 11q23 Workshop participants. Leukemia 12 (1998) 792-800
41. Szilvassy S.J., Ragland P.L., Miller C.L., and Eaves C.J. The marrow homing efficiency of murine hematopoietic stem cells remains constant during ontogeny. Exp. Hematol. 31 (2003) 331-338
42. Terskikh A.V., Miyamoto T., Chang C., Diatchenko L., and Weissman I.L. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 102 (2003) 94-101
43. Trott K.R. Tumour stem cells: The biological concept and its application to cancer treatment. Radiother. Oncol. 30 (1994) 1-5
44. Verlinden S.F., van Es H.H., and van Bekkum D.W. Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice. Exp. Hematol. 26 (1998) 627-630
45. Wang J., Iwasaki H., Krivtsov A., Febbo P.G., Thorner A.R., Ernst P., Anastasiadou E., Kutok J.L., Kogan S.C., Zinkel S.S., et al. Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. EMBO J. 24 (2005) 368-381
46. Yang F.C., Atkinson S.J., Gu Y., Borneo J.B., Roberts A.W., Zheng Y., Pennington J., and Williams D.A. Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration and mobilization. Proc. Natl. Acad. Sci. USA 98 (2001) 5614-5618
47. Yuan Y., Shen H., Franklin D.S., Scadden D.T., and Cheng T. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat. Cell Biol. 6 (2004) 436-442